NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1255338307 M.D.
Verify on CMS → Samuel Boles, M.D.
Ophthalmology Physician in Annapolis, Maryland.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,090 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 620 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
44%
generic claims · 56% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
62.3/100
▼ 21 pts below national avg 83.1 · Mid-tier
Industry payments
$1.5K
45 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Samuel Boles, M.D. reported a CMS MIPS final score of 62.3/100 - below the 83.1 national average - and filed 2,513 Medicare Part D claims in 2023.
- 62.3/100
- MIPS score · -21 vs avg
- 3K
- Part D claims, 2023
- 44%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Samuel Boles, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
62 6th percentile higher than 6% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Samuel Boles, M.D. sits
This provider among ophthalmology physician peers
Across the 9,866 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Samuel Boles, M.D. writes more Part D claims than 80% of them and scores higher on MIPS quality than 7% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Samuel Boles, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Samuel Boles, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Samuel Boles, M.D.?
Below national averagePrimary specialty
Ophthalmology Physician
Medicare Part D claims
2,513 77% vs specialty avg
MIPS final score
62.3/100 20.8 pts vs avg
Specialty distribution in Maryland
How Ophthalmology Physician compares to other specialties among Maryland providers
Medicare quality performance, MIPS
Samuel Boles, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 62.3/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) - 62.3/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Samuel Boles, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 127 LUBRANO DR, Annapolis, MD, 21401, with a listed phone of (410) 224-2010. NPI 1255338307 was issued on 07/05/2005.
Medicare Part D records for calendar year 2023 show 2,513 prescription claims written by this provider, covering 620 Medicare beneficiaries and totaling roughly $652K in drug spend, split 56% brand-name and 44% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 62.3/100 for the 2023 performance year (Quality 67.1, Cost 18.9), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1255338307 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/05/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
62.3218
Final Score
Avg: 83.1
67.1237
Quality
18.949
Cost
86
Promoting Interoperability
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Samuel Boles, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.5K
Largest payer
Bausch & Lomb Americas Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Samuel Boles, M.D. - brand share 56.0%
Ophthalmology Physician average
56% brand-name claims vs 44% generic, on 2,513 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
2,513
Total Claims
$652K
Total Drug Cost
620
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,889
- Total Day Supply
- 140,556
- Brand vs Generic
- 56% brand / 44% generic
- Brand Drug Cost
- $578K
- Generic Drug Cost
- $74K
Patient Demographics
- Average Patient Age
- 75.2 years
- Avg HCC Risk Score
- 1.08
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 23, 65-74: 274, 75-84: 251, 85+: 72
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Samuel Boles, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
566 claims
- Lumigan
Lumigan
318 claims
- Dorzolamide-Timolol 202
Dorzolamide-Timolol
202 claims
- Prednisolone Acetate 163
Prednisolone Acetate
163 claims
- Travoprost 120
Travoprost
120 claims
- Simbrinza 103
Simbrinza
103 claims
- Besivance 91
Besivance
91 claims
- Vyzulta 71
Vyzulta
71 claims
| Drug | Claims |
|---|---|
| Latanoprost | 566 |
| Lumigan Bimatoprost | 318 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 202 |
| Prednisolone Acetate | 163 |
| Travoprost | 120 |
| Simbrinza Brinzolamide/Brimonidine Tart | 103 |
| Besivance Besifloxacin Hcl | 91 |
| Vyzulta Latanoprostene Bunod | 71 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 69 |
| Dorzolamide Hcl | 68 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Samuel Boles, M.D. fits within the Ophthalmology Physician landscape nationally.
22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider
Samuel Boles, M.D.'s 2,513 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as Boles.
Dr. Abdulrahman Abodarahim
MBBCH
Baltimore, MD
Dr. Donald Abrams
M.D.
Baltimore, MD
Dr. Lisa Abrams
M.D.
Lutherville, MD
Dr. Neal Adams
MD
Silver Spring, MD
Dr. Arturo Aglubat
M.D.
Bel Air, MD
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Maryland medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Maryland
Frequently Asked Questions
What is Samuel Boles, M.D.'s specialty? ▼
Samuel Boles, M.D. specializes in Ophthalmology Physician and practices in Annapolis, Maryland. Credentials: M.D..
How much does Samuel Boles, M.D. prescribe under Medicare Part D? ▼
In 2023, Samuel Boles, M.D. wrote 2,513 Medicare Part D claims totaling $652K in drug costs for 620 beneficiaries.
What is Samuel Boles, M.D.'s Medicare quality score? ▼
Samuel Boles, M.D. has a CMS MIPS Final Score of 62.3/100 (Quality: 67.1, Cost: 18.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Samuel Boles, M.D. located? ▼
Samuel Boles, M.D. is located at 127 LUBRANO DR, Annapolis, MD, 21401. Phone: (410) 224-2010.
What is Samuel Boles, M.D.'s NPI number? ▼
Samuel Boles, M.D.'s National Provider Identifier (NPI) is 1255338307, issued on 07/05/2005.
Does Samuel Boles, M.D. prescribe more brand-name or generic drugs? ▼
Samuel Boles, M.D.'s prescribing is 56% brand-name and 44% generic drugs by claim count, with $578K in brand drug costs.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does Samuel Boles, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Samuel Boles, M.D.'s most frequently prescribed drugs include Latanoprost, Lumigan, Dorzolamide-Timolol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Samuel Boles, M.D. accept Medicare? ▼
Samuel Boles, M.D. appears in CMS Medicare data with 2,513 Part D claims and 620 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Samuel Boles, M.D.'s credentials? ▼
Samuel Boles, M.D.'s NPI is 1255338307 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.